Top-News

Bio-Techne Aktie News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH Branche:  Biotechnologie Land:  USA
61,69 $
-1,85 $
-2,91%
52,981 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
8,01 Mrd. €
Streubesitz
-
KGV
109,47
Dividende
0,080 $
Dividendenrendite
0,13%
neu: Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Bio-Techne News

31.07.25 - PR Newswire
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering PR Newswire
17.07.25 - PR Newswire
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
Bio-​Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results PR Newswire
15.07.25 - PR Newswire
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
Bio-​Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection PR Newswire
14.07.25 - PR Newswire
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Bio-​Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-​Based Gene Therapy PR Newswire
04.07.25 - LYNX Analysen
Bio-Techne: Innovation, Expansion und ein möglicher Kursausbruch
Bio-​Techne könnte vor einem Wachstumsschub stehen. Bisher wird das nicht nur ignoriert, sondern mit einem Kurssturz quittiert. Jetzt vollständige Analyse lesen
24.06.25 - PR Newswire
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
Bio-​Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development PR Newswire
10.06.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics PR Newswire
29.05.25 - PR Newswire
Bio-Techne to Present at Investor Conferences
Bio-​Techne to Present at Investor Conferences PR Newswire
14.05.25 - PR Newswire
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) PR Newswire
12.05.25 - PR Newswire
Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
Bio-​Techne to Showcase Next-​Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 PR Newswire
08.05.25 - PR Newswire
Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
Kytopen and Bio-​Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing PR Newswire
08.05.25 - PR Newswire
Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
Bio-​Techne to Present at the BofA Securities 2025 Health Care Conference PR Newswire
07.05.25 - PR Newswire
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
BIO-​TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS PR Newswire
07.05.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
BIO-​TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM PR Newswire
06.05.25 - PR Newswire
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. PR Newswire
29.04.25 - PR Newswire
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy PR Newswire
24.04.25 - PR Newswire
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
Bio-​Techne Announces Early Access Program for Next-​Generation Spatial Protein Proximity Detection PR Newswire
23.04.25 - PR Newswire
Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Bio-​Techne to Showcase Cutting-​Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting PR Newswire
15.04.25 - PR Newswire
Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
Bio-​Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results PR Newswire
02.04.25 - PR Newswire
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
Leica Biosystems and Bio-​Techne Expand Partnership to Enable Protease-​Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument PR ...

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »